Loading…
← CockpitCompetitor Analysis › GHC.MI Garofalo Health Care S.P.A.Open in the cockpit ↗

Garofalo Health Care S.P.A.GHC.MICompetitor analysis, valuation and peers

Italy · EUR·Health Care›Hospital/Nursing Management
Momentum weak 30
Mkt cap
$508M
US dollars, full cap
Free float
23%
of shares outstanding
$/day
$71,030
20-day average traded
Fwd P/E
20.5×
forward earnings
ROIC−WACC
+0.4 pp
WACC 5.9%
Hurdle
-17 pp
Req g minus delivered
Next earnings
14 days
2 Dec 2026
Close · EUR€5.16
1D-0.8%
1W-3.7%
1M-2.6%
3M-7.9%
6M-3.0%
YTD-7.7%
1Y-1.5%
ATR %1.6%
52w lowhigh13.3% off high

What Garofalo Health Care does

Employees: 2,714

Garofalo Health Care at a glance

Size Garofalo Health Care (GHC.MI) is an Italy Health Care company (Hospital/Nursing Management) with a market value of $508M, the 107th largest of 121 Italy companies the cockpit tracks. Shares closed at €5.16 on 18 Nov 2026.

Performance Over six months the shares fell 3.0%, against -5.6% for the median peer and +3.1% for the Italy market (cap-weighted) — 9th highest of 19 in its peer set.

Growth Revenue grew 3.7% over the last twelve months (peer median +11.9%); the operating margin is 10.4% (peer median 10.4%).

Valuation It trades at 20.5× forward earnings against a peer median of 22.5× (7th cheapest of 14).

Price implies For today's price to make sense, revenue must grow about 2% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -17 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.4 points above its cost of capital (5.9% WACC).

Next results Next results expected around 2 Dec 2026 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026GHC.MI 98Peer median 93
Six months, rebased to 100: Garofalo Health Care against the median of its 20 peers (local-currency closes).

Garofalo Health Care financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€487M€479M€462M€361M€315M
Revenue growth—+4%+28%+15%—
Gross profit€67.5M€121M€120M€96.5M€88.1M
EBITDA€80.1M€75.7M€73.8M€61.8M€52.6M
Net income€19.2M€23.4M€21.7M€20.8M€21.4M
Free cash flow€15.3M€18.1M€16.7M€34.6M€30.2M
Capital expenditure€42.6M€33.5M€21.6M€17.1M€15.0M
Total debt€243M€226M€230M€228M€176M

Quarterly statements and history in the cockpit →

Garofalo Health Care competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%ARTEMISMED6062VOX15153012392609INDRAMEDCO301103KOVAIVMDQC7HCGGDSCBAVJLHLRHKGHC.MI6-month return →1-month return →
Up and to the right = strong over both horizons. Garofalo Health Care is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×ARTEMISMED6062VOX1515301239INDRAMEDCOVMDQC7HCGCBAVJLHLRHKPARKHOSPSGHC.MIRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Garofalo Health Care is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%ARTEMISMED6062VOX15153012392609INDRAMEDCOKMCSHIL301103KOVAIVMDQC7A50GDSCBAVPARKHOSPSGHC.MIGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Garofalo Health Care is the large dot.

Garofalo Health Care competitors and peer comparison

How Garofalo Health Care compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Garofalo Health Care against its 20 peers (data as of 18 Nov 2026)
MeasureGHC.MIPeer medianRank in peer set
1-month return-2.6%+2.1%9th lowest of 20
6-month return-3.0%-5.6%9th highest of 19
Distance from 52-week high-13.3%-22.3%9th highest of 21
Revenue growth (TTM)+3.7%+11.9%6th lowest of 21
Operating margin10.4%10.4%11th highest of 21
Forward P/E20.5×22.5×7th cheapest of 14
Growth the price implies (Req g, 7 yrs)1.7%7.2%6th least demanding of 17
Growth delivered (Del g)+18.3%+15.5%6th highest of 17
Hurdle (Req g minus delivered)-16.5 pp-4.9 pp5th least demanding of 17
ROIC minus cost of capital+0.4 pp+1.1 pp10th lowest of 21
EV / EBITDA8.6×14.6×6th cheapest of 18
Net debt / EBITDA2.7×0.3×5th most indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are Garofalo Health Care's closest peers?
The cockpit's peer set: Artemis Medicare Services (ARTEMISMED.NS), Charm Care (6062.T), Voxel (VOX.WA), China Resources Medical (1515.HK), Bright Eye Hospital (301239.SZ), Bayzed Health (2609.HK), Indraprastha Medical (INDRAMEDCO.NS), KMC Speciality Hospitals (India) (KMCSHIL.NS).
Is Garofalo Health Care expensive compared with its peers?
On forward p/e it trades at 20.5× against a peer median of 22.5×, 7th cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about 2% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -17 pp: the price already allows for a slowdown.
How has Garofalo Health Care stock performed?
Over six months to 18 Nov 2026 the shares returned -3.0% against -5.6% for the median peer; over one year -1.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.